Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Near Infrared Fluorescence Imaging: early-phase trial registry

1 of 1 indexed Near Infrared Fluorescence Imaging trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Near Infrared Fluorescence Imaging: 1 US clinical trial tracked, 1 recruiting.

Near Infrared Fluorescence Imaging is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Abramson Cancer Center at Penn Medicine, running 1 of these trials.

Enrollment posture brief

Registry condition near-infrared-fluorescence-imaging

OPEN 1 | RECR 100% | LATE 0 | EARLY 1 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Near Infrared Fluorescen (th…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Near Infrared Fluorescence Imaging

Near Infrared Fluorescence Imaging lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Near Infrared Fluorescence Imaging on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Near Infrared Fluorescence Imaging is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Near Infrared Fluorescence Imaging records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

1788 4K Camera System with Advanced Imaging Modality Device
1 trials
CYTALUX™ (pafolacianine) Drug
1 trials

US sites by state

Facility locations filed on Near Infrared Fluorescence Imaging trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Near Infrared Fluorescence Imaging page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Near Infrared Fluorescence Imaging condition card totals 1 registered trials; most-linked intervention 1788 4K Camera System with Advanced Imaging Modality; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.